4//SEC Filing
Chang David D 4
Accession 0001214659-21-003609
CIK 0001737287other
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 4:57 PM ET
Size
9.4 KB
Accession
0001214659-21-003609
Insider Transaction Report
Form 4
Chang David D
DirectorPresident and CEO
Transactions
- Award
Common Stock
2021-03-26+80,452→ 2,284,869 total - Award
Stock Option (Right to Buy)
2021-03-26+298,836→ 298,836 totalExercise: $33.78Exp: 2031-03-26→ Common Stock (298,836 underlying)
Holdings
- 1,201,108(indirect: See footnote)
Common Stock
- 650,266(indirect: See footnote)
Common Stock
- 650,266(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]Securities held in the name of the Chang 2006 Family Trust.
- [F2]Securities held in the name of the JEC 2019 Trust dated October 1, 2019.
- [F3]Securities held in the name of the RTC 2019 Trust dated October 1, 2019.
- [F4]25% of the shares subject to the stock option shall vest on March 13, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001611024
Filing Metadata
- Form type
- 4
- Filed
- Mar 29, 8:00 PM ET
- Accepted
- Mar 30, 4:57 PM ET
- Size
- 9.4 KB